Buyback of equity shares from open market worth Rs 69.7 crore at Rs 500 per share
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 2.0 pts more than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Advanced Enzyme Technologies announced a buyback of equity shares from the open market through NSE and BSE for up to Rs 69.7 crore at a maximum price of Rs 500 per share (face value Rs 2). The offer opens on August 14, 2026 and closes by November 20, 2026. Up to 13.94 lakh shares may be bought back, about 1.25 percent of paid-up equity capital. The Rs 500 price carries a premium of 42 to 59 percent over recent market prices. Promoters will not participate. Funded from free reserves.
Return of surplus cash to shareholders, likely to support stock price in short term; reduces equity base and may lift EPS.